{"doi":"10.1016/j.jhep.2020.09.024","title":"Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study","abstract":"•Patients with cirrhosis experience high rates of hepatic decompensation and death following SARS-CoV-2 infection.•Mortality increased in stepwise fashion according to Child-Pugh class.•Other risk factors for death included advancing age and alcohol-related liver disease.•Mortality risk was higher in patients with advanced cirrhosis than propensity-score-matched controls without liver disease.•The majority of deaths in patients with cirrhosis were from COVID-19-related lung disease. Background & AimsChronic liver disease (CLD) and cirrhosis are associated with immune dysregulation, leading to concerns that affected patients may be at risk of adverse outcomes following SARS-CoV-2 infection. We aimed to determine the impact of COVID-19 on patients with pre-existing liver disease, which currently remains ill-defined.MethodsBetween 25th March and 8th July 2020, data on 745 patients with CLD and SARS-CoV-2 (including 386 with and 359 without cirrhosis) were collected by 2 international registries and compared to data on non-CLD patients with SARS-CoV-2 from a UK hospital network.ResultsMortality was 32% in patients with cirrhosis compared to 8% in those without (p <0.001). Mortality in patients with cirrhosis increased according to Child-Pugh class (A [19%], B [35%], C [51%]) and the main cause of death was from respiratory failure (71%). After adjusting for baseline characteristics, factors associated with death in the total CLD cohort were age (odds ratio [OR] 1.02; 1.01–1.04), Child-Pugh A (OR 1.90; 1.03–3.52), B (OR 4.14; 2.4–7.65), or C (OR 9.32; 4.80–18.08) cirrhosis and alcohol-related liver disease (OR 1.79; 1.03–3.13). Compared to patients without CLD (n = 620), propensity-score-matched analysis revealed significant increases in mortality in those with Child-Pugh B (+20.0% [8.8%–31.3%]) and C (+38.1% [27.1%–49.2%]) cirrhosis. Acute hepatic decompensation occurred in 46% of patients with cirrhosis, of whom 21% had no respiratory symptoms. Half of those with hepatic decompensation had acute-on-chronic liver failure.ConclusionsIn the largest such cohort to date, we demonstrate that baseline liver disease stage and alcohol-related liver disease are independent risk factors for death from COVID-19. These data have important implications for the risk stratification of patients with CLD across the globe during the COVID-19 pandemic.Lay summaryThis international registry study demonstrates that patients with cirrhosis are at increased risk of death from COVID-19. Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease. Chronic liver disease (CLD) and cirrhosis are associated with immune dysregulation, leading to concerns that affected patients may be at risk of adverse outcomes following SARS-CoV-2 infection. We aimed to determine the impact of COVID-19 on patients with pre-existing liver disease, which currently remains ill-defined. Between 25th March and 8th July 2020, data on 745 patients with CLD and SARS-CoV-2 (including 386 with and 359 without cirrhosis) were collected by 2 international registries and compared to data on non-CLD patients with SARS-CoV-2 from a UK hospital network. Mortality was 32% in patients with cirrhosis compared to 8% in those without (p <0.001). Mortality in patients with cirrhosis increased according to Child-Pugh class (A [19%], B [35%], C [51%]) and the main cause of death was from respiratory failure (71%). After adjusting for baseline characteristics, factors associated with death in the total CLD cohort were age (odds ratio [OR] 1.02; 1.01–1.04), Child-Pugh A (OR 1.90; 1.03–3.52), B (OR 4.14; 2.4–7.65), or C (OR 9.32; 4.80–18.08) cirrhosis and alcohol-related liver disease (OR 1.79; 1.03–3.13). Compared to patients without CLD (n = 620), propensity-score-matched analysis revealed significant increases in mortality in those with Child-Pugh B (+20.0% [8.8%–31.3%]) and C (+38.1% [27.1%–49.2%]) cirrhosis. Acute hepatic d","journal":"Journal of Hepatology","year":2020,"id":48173,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":527,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9602,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":226653,"name":"Andrew M. Moon","orcid":"0000-0001-7163-2062","position":1,"is_corresponding":false},{"id":226654,"name":"Jonathan Cook","orcid":"0000-0002-4156-6989","position":2,"is_corresponding":false},{"id":3833,"name":"Sherief Abd-Elsalam","orcid":"0000-0003-4366-2218","position":3,"is_corresponding":false},{"id":226655,"name":"Costica Aloman","orcid":"0000-0002-2888-1984","position":4,"is_corresponding":false},{"id":226656,"name":"Matthew J. Armstrong","orcid":"0000-0002-3425-1161","position":5,"is_corresponding":false},{"id":226657,"name":"Elisa Pose","orcid":"0000-0002-0224-7686","position":6,"is_corresponding":false},{"id":109030,"name":"Erica J. Brenner","orcid":"0000-0003-0292-3637","position":7,"is_corresponding":false},{"id":226658,"name":"Tamsin Cargill","orcid":"0000-0002-2863-0835","position":8,"is_corresponding":false},{"id":229485,"name":"M.-A Catana","orcid":null,"position":9,"is_corresponding":false},{"id":70031,"name":"Renumathy Dhanasekaran","orcid":"0000-0001-8819-7511","position":10,"is_corresponding":false},{"id":226659,"name":"Ahad Eshraghian","orcid":"0000-0003-0751-5712","position":11,"is_corresponding":false},{"id":226660,"name":"Ignacio García‐Juárez","orcid":"0000-0003-2400-1887","position":12,"is_corresponding":false},{"id":226661,"name":"Upkar S. Gill","orcid":"0000-0001-6146-9708","position":13,"is_corresponding":false},{"id":226662,"name":"Patricia D. Jones","orcid":"0000-0003-4189-6731","position":14,"is_corresponding":false},{"id":226663,"name":"James Kennedy","orcid":"0000-0001-9335-0808","position":15,"is_corresponding":false},{"id":79295,"name":"Aileen Marshall","orcid":"0000-0003-3283-6315","position":16,"is_corresponding":false},{"id":226664,"name":"Charmaine Matthews","orcid":"0000-0002-7387-8792","position":17,"is_corresponding":false},{"id":97689,"name":"George Mells","orcid":"0000-0002-7962-5286","position":18,"is_corresponding":false},{"id":229486,"name":"Carolyn Mercer","orcid":null,"position":19,"is_corresponding":false},{"id":226665,"name":"Ponni Perumalswami","orcid":"0000-0003-3070-3906","position":20,"is_corresponding":false},{"id":226666,"name":"Emma Avitabile","orcid":"0000-0001-8927-1242","position":21,"is_corresponding":false},{"id":229487,"name":"Xialong Qi","orcid":null,"position":22,"is_corresponding":false},{"id":226667,"name":"Feng Su","orcid":"0000-0002-7707-1072","position":23,"is_corresponding":false},{"id":226668,"name":"Nneka N. Ufere","orcid":"0000-0001-8255-9374","position":24,"is_corresponding":false},{"id":226669,"name":"Yu Jun Wong","orcid":"0000-0002-0727-1183","position":25,"is_corresponding":false},{"id":162520,"name":"Ming-Hua Zheng","orcid":"0000-0003-4984-2631","position":26,"is_corresponding":false},{"id":106107,"name":"Eleanor Barnes","orcid":"0000-0002-0860-0831","position":27,"is_corresponding":false},{"id":226670,"name":"A. Sidney Barritt","orcid":"0000-0002-4200-3256","position":28,"is_corresponding":false},{"id":226671,"name":"Gwilym J. Webb","orcid":"0000-0002-0710-5644","position":29,"is_corresponding":false},{"id":226652,"name":"Thomas Marjot","orcid":"0000-0002-6542-6323","position":0,"is_corresponding":true}],"reference_count":54,"raw_metadata":null,"created_at":"2026-07-18T20:34:12.647743Z","pmid":"33035628","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}